RxDoctor Payments Data

Jay Patel, DO

Adult Reconstructive Orthopaedic Surgery · Fall River, MANPI 1962841452

Payments from drug & device makers

What this record shows

This record is dominated by education: $42,000 of the $52,313 with a category attached, or 80.3%. Smith+Nephew accounts for 82.4% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2021 at $21,221 and has fallen 99.1% since, to $191 in 2025.

$52,313in general payments, 2019–2025

Across 105 payments — averaging $498.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$43K
  • Medacta USA, Inc.$5K
  • FX Shoulder Solutions, Inc$2K
  • Microport Orthopedics Inc$598
  • Ortho Development Corporation$261
  • Jazz Pharmaceuticals Inc.$207
  • plus $1K from 19 others
$98,461in research payments, 2019–2025

Across 18 payments — averaging $5470.06 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$98K

What the payments were for

  • Travel & lodging$6,74813%
  • Food & beverage$3,5657%
  • Education$42,00080%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$52,313 in reported general payments places this provider in the 70th percentile of 24 adult reconstructive orthopaedic surgery providers in Massachusetts.

See all adult reconstructive orthopaedic surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$135,912
Medicare patients
348
Services billed
3,976

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam318$1,173
Oxycodone Hcl55$435
Etodolac11$356
Tramadol Hcl76$273
Cefadroxil12$65

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Fall River

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →